Seasoned operator and investor focused on technology and growth-stage companies, Damir Durkovic combines founder-level operating experience with early-stage venture investing and strategic advisory work. He has led product, go-to-market and M&A initiatives in software and fintech businesses, sits on several private company boards, and sources deals across EMEA. Educational foundation includes engineering and business studies. Market-facing profile emphasizes scaling revenue, capital strategy and exit planning.
Seasoned operator and investor focused on technology and growth-stage companies, Damir Durkovic combines founder-level operating experience with early-stage venture investing and strategic advisory work. He has led product, go-to-market and M&A initiatives in software and fintech businesses, sits on several private company boards, and sources deals across EMEA. Educational foundation includes engineering and business studies. Market-facing profile emphasizes scaling revenue, capital strategy and exit planning.
Combines a founder-operator lens with disciplined early-stage venture investing, prioritizing SaaS and fintech businesses with clear product-market fit and repeatable revenue models. Focuses on backing teams where he can add tangible go-to-market and product scaling expertise, structuring capital to bridge growth to exit and de-risk through staged milestones. Investment horizon is growth-to-exit, favoring revenue-driven metrics, unit-economics improvement, and pragmatic M&A-aware planning while maintaining concentrated, board-level active portfolio involvement.
Combines a founder-operator lens with disciplined early-stage venture investing, prioritizing SaaS and fintech businesses with clear product-market fit and repeatable revenue models. Focuses on backing teams where he can add tangible go-to-market and product scaling expertise, structuring capital to bridge growth to exit and de-risk through staged milestones. Investment horizon is growth-to-exit, favoring revenue-driven metrics, unit-economics improvement, and pragmatic M&A-aware planning while maintaining concentrated, board-level active portfolio involvement.
| Trades 8092 | Longs Won 3887/8092 48% | Profit Factor 1.69 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $669,316.17 |
| Average Win $242,567.33 | Best Trade (Jun 30) $26.62M | Sharpe Ratio -9.57 |
| Average Loss -$132,317.84 | Worst Trade (Oct 15) -$6.69M | Z-Score -4.68 (100%) |
| Commissions $0 | Avg. Trade Length 5m 1w 1d | Expectancy $48,521.96 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 18,868 | 16,981 | 15,094 | 13,208 | 11,321 | 9,434 | 7,547 | 5,660 | 3,774 | 1,887 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 14,321 | $1.63M | $2.51M | - | $877,447.73 | 53.76% | +0.718% |
AA Alcoa Corporation | 51,792 | $3.44M | $2.08M | - | -$1.35M | -39.44% | +0.225% |
AAL American Airlines Group Inc. | 209,443 | $2.25M | $2.52M | - | $274,370.31 | 12.2% | +2.205% |
AAON Aaon Inc. | 5,594 | $709,655 | $430,290.48 | - | -$279,364.52 | -39.37% | -4.483% |
ABBV AbbVie Inc. | 64,317 | $16.18M | $18.52M | - | $2.33M | 14.41% | +1.556% |
ABNB Airbnb, Inc. | 95,328 | $13.64M | $16.46M | - | $2.82M | 20.66% | +3.358% |
ABT Abbott Laboratories | 105,540 | $12M | $11.04M | - | -$962,571.75 | -8.02% | +1.554% |
ACA Arcosa Inc. | 8,550 | $1.24M | $1.26M | - | $14,962 | 1.2% | +0.02% |
ACDC ProFrac Holding Corp. | 27,022 | $156,998 | $107,142.23 | - | -$49,855.77 | -31.76% | -5.819% |
ACI Albertsons Companies, Inc. | 104,471 | $1.41M | $1.38M | - | -$36,042.87 | -2.55% | +0.803% |
ACM Aecom | 42,958 | $3.24M | $2.53M | - | -$704,255.65 | -21.75% | +1.097% |
ACMR Acm Research Inc. | 2,068 | $262,409 | $116,717.92 | - | -$145,691.08 | -55.52% | -7.657% |
ADC Agree Realty Corporation | 76,208 | $5.65M | $5.09M | - | -$557,438.18 | -9.86% | +1.921% |
ADEA Adeia Inc. | 7,718 | $185,463.75 | $163,786.77 | - | -$21,676.98 | -11.69% | -1.798% |
ADM Archer-Daniels-Midland Co | 26,035 | $1.5M | $2.17M | - | $668,579.08 | 44.67% | -0.562% |
ADMA Adma Biologics Inc. | 22,602 | $189,179 | $243,310.53 | - | $54,131.53 | 28.61% | +4.11% |
ADPT Adaptive Biotechnologies Corporation | 5,081.25 | $435,971.25 | $130,994.62 | - | -$304,976.63 | -69.95% | +0.625% |
ADTN Adtran Holdings, Inc. | 23,203 | $277,883.53 | $150,471.45 | - | -$127,412.08 | -45.85% | -2.334% |
AEE Ameren Corporation | 68,416 | $7.54M | $7.11M | - | -$432,505.72 | -5.73% | -0.612% |
AEG Aegon N.V. | 127,979 | $951,888.18 | $1.06M | - | $105,858.25 | 11.12% | +0.303% |